IPCA Laboratories Limited — Investor Meet, 30-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates
30-05-2025 | 05:19 pm
30-05-2025 | 05:19 pm
Ipca Laboratories discussed Q4 FY25 earnings, highlighting steady revenue growth and margin stability. Management emphasized strong operational execution and ongoing initiatives driving business momentum. The focus remains on expanding product portfolio and enhancing market presence, with a positive outlook on growth drivers and margin improvement prospects.
No comments yet. Be the first to comment!
